ArticleFrontiers in medicine2026
Study on the combined application of selected virtual monoenergetic imaging, virtual non-contrast imaging, and adaptive statistical iterative reconstruction-V in head and neck CT angiography using 256-slice wide-body CT.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the value of combining spectral CT-derived virtual monoenergetic imaging, adaptive statistical iterative reconstruction-V (ASIR-V), and virtual non-contrast imaging in head and neck CT angiography (CTA) for patients with cerebrovascular disease (CVD). Methods: 150 patients undergoing head and neck CTA for suspected or known CVD were randomly assigned 1:1:1 to the conventional-dose, spectral low-dose, and spectral ultra-low-dose groups. The conventional-dose group underwent a true non-contrast scan followed by 100-kVp polychromatic CTA with filtered back projection (FBP) reconstruction and received 0.90 mL/kg contrast at 5.0 mL/s, whereas the two spectral groups underwent a single GSI CTA acquisition generating virtual non-contrast images. Reported conventional-group DLP and ED included both acquisitions. The spectral low-dose group used 65-keV, 50% ASIR-V reconstruction and received 0.55 mL/kg at 4.5 mL/s, whereas the ultra-low-dose group used 60-keV, 70% ASIR-V reconstruction and received 0.50 mL/kg at 4.0 mL/s. Vascular CT attenuation, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), subjective image quality, dose-length product (DLP), effective dose (ED), total contrast agent volume, and total iodine load were compared among groups. Results: CT values of the aortic arch, common carotid artery, internal carotid artery, and M1 segment, and cervical and cerebral vascular SNR and CNR, were lower in both spectral groups than in the conventional-dose group ( Conclusion: The integrated spectral CT protocols incorporating selected virtual monoenergetic imaging, ASIR-V reconstruction, and virtual non-contrast imaging were associated with lower radiation exposure and contrast agent use while maintaining diagnostically acceptable image quality, supporting the preliminary feasibility of the evaluated dose-reduction protocols in head and neck CTA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.